Get access to our best features

Get access to our best features

U.S. FDA removes COVID test requirements for Pfizer, Merck pills

Summary by Ground News
Pfizer's Paxlovid and Merck's Lagevrio pills were given emergency use authorizations in Dec. 2021. FDA said the patients should have a current diagnosis of mild-to-moderate COVID infection. Individuals with recent known exposure with signs and symptoms may be diagnosed by their healthcare providers with COVID even if they have a negative test result.
Published 4 months ago

News Articles

More
Filters
All
Left
Center
Right
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

50% of the sources are Center, 50% of the sources lean Right
Reuters
Times of India
C 50%
R 50%
See less detail